Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
✍ Scribed by Kiladjian, J-J; Chomienne, C; Fenaux, P
- Book ID
- 109886646
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 168 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Interferon‐alpha (IFN‐α) has shown significant activity in the treatment of BCR‐ABL–negative myeloproliferative disorders (MPDs), particularly essential thrombocythemia (ET) and polycythemia vera (PV). PEG‐IFN‐α‐2b is a pegylated IFN‐α‐2b with a significant advantage ove
## Abstract Chromosomal deletions of band 13q14 occur recurrently in __BCR/ABL__ negative chronic myeloproliferative disorders (CMPD), including myelosclerosis with myeloid metaplasia (MMM), polycythemia vera (PV), essential thrombocythemia (ET), juvenile chronic myeloid leukemia (JCML), and the so